The role of glutamate and its receptors in migraine

CNS and Neurological Disorders - Drug Targets

Volumn 6, Issue 4, 2007, Pages 251-257

  Vikelis, Michail ^a   Mitsikostas, Dimos D ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

Author keywords

AMPA; Cortical spreading depression; Glutamate; Kainate; Metabotropic receptors; Migraine; Neuronal hyperexcitability; NMDA

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 (4 CARBOXYBENZYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 3 ISOQUINOLINECARBOXYLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; AMPA RECEPTOR; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; DIZOCILPINE MALEATE; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; ION CHANNEL; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; KETAMINE; LY 435735; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PLACEBO; PLASMA PROTEIN; PROTEIN C FOS; SUMATRIPTAN; UNCLASSIFIED DRUG;

ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL TRIAL; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ELECTROPHYSIOLOGY; HUMAN; MIGRAINE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SENSITIZATION; SPREADING CORTICAL DEPRESSION; SYMPTOM; THROMBOCYTE; TRIGEMINAL NUCLEUS; UNSPECIFIED SIDE EFFECT;

ANIMALS; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; MIGRAINE DISORDERS; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TRIGEMINAL NERVE;

EID: 34547786030     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152707781387279     Document Type: Article

References (74)

1. Greenamyre, J.T.; Porter, R.H. Neurology, 1994, 44, S7.
2. Meldrum, B.S. J. Nut., 2000, 130, 1007S.
3. Bleakman, D.; Lodge, D. Neuropharmacology, 1998, 37, 1187.
4. Ziff E.B. Ann. N. Y. Acad. Sci., 1999, 465.
5. Dickenson, H.; Chapman, V.; Green, G.M. Gen. Pharmacol., 1997, 28, 633.
6. Vandenberg, R.J. Clin. Exp. Pharmacol Physiol., 1998, 25, 393.
7. Takahashi, M.; Billups, B.; Rossi, D.; Sarantis, M.; Hamann, M.; Attwell, D. J. Exp. Biol., 1997, 200, 401.
8. Gegelashvili, G.; Schousboe, A. Mol. Pharmacol., 1997, 52, 6.
9. Brauner-Osborne, H.; Egebjerg, J.; Nielsen, E.O.; Madsen, U.; Krogsgaard-Larsen, P. J. Med. Chem., 2000, 43, 2609.
10. Fundytus, M.E. CNS Drugs, 2001, 15, 29.
11. Schoepp, D.D.; Conn, P.J. Pharmacol. Biochem. Behav., 2002, 74, 255.
12. Watkins, J.C. Adv. Biochem. Psychopharmacol., 1981, 29, 205.
13. Husi, H. Int. Rev. Neurobiol., 2004, 61, 49.
14. Gouaux, E. J. Physiol., 2004, 554, 249.
15. Huettner, J.E. Prog. Neurobiol., 2003, 70, 387.
16. Ozawa, S.; Kamiya, H.; Tsuzuki, K. Prog. Neurobiol., 1998, 54, 581.
17. Gibb, A.J. Trends Neurosci., 2004, 27, 7.
18. Dickson, K.S.; Kind, P.C. Curr. Biol., 2003, 13, R920.
19. Erreger, K.; Chen, P.E.; Wyllie, D.J.; Traynelis, S.F. Crit. Rev. Neurobiol., 2004, 16, 187.
20. Nong, Y.; Huang, Y.Q.; Salter, M.W. Curr. Opin. Neurobiol., 2004, 14, 353.
21. Ciabarra, A.M.; Sullivan, J.M.; Gahn, L.G.; Pecht, G.; Heinemann, S.; Sevarino, K.A. J. Neurosci., 1995, 15, 6498.
22. Nishi, M.; Hinds, H.; Lu, H.P.; Kawata, M.; Hayashi, Y. J. Neurosci., 2001, 21, RC185.
23. Matsuda, K.; Kamiya, Y.; Matsuda, S.; Yuzaki, M. Mol. Brain Res., 2002, 100, 43.
24. Ishihama, K.; Turman, J.E. Brain Res., 2006, 1095, 12.
25. Jayakar, S.S.; Dikshit, M. Int. J. Neurosci., 2004, 114, 695.
26. Esteban, J.A. Mol. Interv., 2003, 3, 375.
27. Suzuki, T.; Tsuzuki K.; Kameyama, K.; Kwak, S. Nippon Yakurigaku Zasshi, 2003,122, 515.
28. Schoepp, D.D.; Jane, D.E.; Monn, J.A. Neuropharmacology, 1999, 38, 1431.
29. Marchetti, C.; Taccola, G.; Nistri, A.Eur. J. Neurosci., 2003, 18, 1873.
30. Naples, M.A.; Hampson, D.R. Neuropharmacology, 2001, 40, 170.
31. Pellicciari, R.; Costantino, G.; Macchiarulo, A. Pharm. Acta Helv., 2000, 74, 231.
32. Conn, P.J.; Pin, J.P. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 205.
33. Sahara, Y.; Noro, N.; Iida, Y.; Soma, K.; Nakamura, Y. J. Neurosci., 1997, 17, 6611.
34. Quartu, M.; Serra, M.P.; Ambu, R.; Lai, M.L.; Del Fiacco, M. Mech. Ageing Dev., 2002, 123, 463.
35. Tallaksen-Greene, S.J.; Young, A.B.; Penney, J.B.; Beitz, A.J. Neurosci Lett., 1992, 141, 79.
36. Watanabe, M.; Mishina, M.; Inoue, Y. Neurosci. Lett., 1994, 165, 183.
37. Furuyama, T.; Kiyama, H.; Sato, K.; Park, H.T.; Maeno, H.; Takagi, H.; Tohyama, M. Brain Res. Mol. Brain. Res., 1993, 18, 141.
38. Huettner, J.E. Neuron, 1990, 59 255.
39. Sato, K.; Kiyama, H.; Park, H.T.; Tohyama, M. Neuroreport, 1993, 4, 1263.
40. Sato, K.; Kiyama, H.; Park, H.T.; Sharp, F.R. Exp. Neurol., 1990, 109, 323.
41. Iida, Y. Kokubyo Gakkai Zasshi, 1997, 64, 121.
42. Hill, R.G.; Salt, T.E. J. Physiol., 1992, 327, 65.
43. Bereiter, D.A.; Benetti, A.P. Pain, 1996, 67, 451.
44. Jackson, D.L.; Graff, C.B.; Richardson, J.D.; Hargreaves, K.M. Eur. J. Pharmacol., 1995, 284, 321.
45. Lawand, N.B.; Willis, W.D.; Westlund, K.N. Eur. J. Pharmacol., 1997, 324, 169.
46. Zhou, S.; Bonasera, L.; Carlton, S.M. Neuroreport, 1996 7, 895.
47. Bereiter, D.A.; Bereiter, D.F.; Hathaway, C.B. Pain, 1996 64, 179.
48. Birder, L.A.; Roppolo, J.R.; Erickson, V.L.; de Groat, W.C. Brain Res., 1999, 834, 55.
49. Raigorodsky, G.; Urca; G. Eur. J. Pharmacol., 1990, 182, 37.
50. Ma, Q.P. Neuroreport, 2001, 12, 1589.
51. Scheller, D.; Szathmary, S.; Kolb, J.; Tegtmeier, F. Amino Acids, 2000, 19, 571.
52. Lauritzen, M.; Hansen, AJ.; J. Cereb. Blood Flow Metab., 1992, 12, 223.
53. Nellgard, B.; Wieloch, T. Acta Physiol. Scand., 1992 146, 497.
54. Mody, I.; Lambert, J.D.; Heinemann, U. J. Neurophysiol., 1987, 57, 869.
55. Mitsikostas, D.D.; Sanchez del Rio, M.; Waeber, C.; Huang, Z.; Cutrer, F.M.; Moskowitz, MA. Br. J. Pharmacol., 1999, 127, 623.
56. Moskowitz, M.A.; Macfarlane, R. Cerebrovasc. Brain Metab. Rev., 1993, 5, 159.
57. Mitsikostas, D.D.; Sanchez del Rio, M.; Waeber, C.; Moskowitz, M.; Cutrer, M. Pain, 1998, 76, 239.
58. Classey, J.D.; Knight, Y.E.; Goadsby, P.J. Brain Res., 2001, 907, 117.
59. Ro, J.Y.; Capra, N.F.; Masri, R. Neuroscience, 2004, 123, 213.
60. Hattori, Y.; Watanabe, M.; Iwabe, T.; Tanaka, E.; Nishi, M.; Aoyama, J.; Satoda, T.; Uchida, T.; Tanne, K. Brain Res., 2004, 1021, 183.
61. Johnson, K.W.; Dieckman, D.K.; Phebus, L.A.; Katofiasc M.A.; Cohen, M.L.; Schenok, K.W.; Filla, S.A.; Ornstein, P.L.; Ogden, A.M.; Ramadan, N.; Jarvie, K.; Ho, K.; Bleakman D. Cephalalgia, 2001, 21, 267.
62. Goadsby, P.J.; Classey, J.D. Brain Res., 2000, 875, 119.
63. Storer, R.J.; Goadsby, P.J. Neuroscience, 1999, 90, 1371.
64. Ferrari, M.D.; Odink, J.; Bos, K.D.; Malessy, M.J.; Bruyn, G.W. Neurology 1990, 40, 1582.
65. Alam, Z.; Gooombes, N.; Waring, R.H.; Williams, A.C.; Steventon, G.B. J. Neurol. Sci., 1998, 156, 102.
66. D'Andrea, G.; Cananzi, A.R.; Joseph, R.; Morra, M.; Zamberlan, F.; Ferro Milone. F.; Grunfeld S.; Welch, K.M. Cephalalgia, 1991, 11, 197.
67. Cananzi, A.R.; D'Andrea, G.; Perini, F.; Zamberlan, F.; Welch, K.M. Cephalalgia, 1995, 15, 132.
68. Martinez, F.; Castillo, J:; Rodriguez, J.R.; Leira, R.; Neya, M. Cephalalgia, 1993, 13, 89.
69. D'Eufemia P.; Finocehiaro, R.; Londvai D.; Celli, M.; Viozzi, L.; Troiani, P.; Turri, R., Giardini, O. Cephalalgia, 1997, 17, 652.
70. Kaube, H.; Herzog, J.; Kaufer, T.; Dichgans, M.; Diener, H.C. Neurology, 2000, 55, 139.
71. Ramadan, N.; Sang C.; Chappell, A.; Vandenhende, Johnson, K.; Phebus, L.; Bleakman, D.; Ornstein, P.; Arnold, B.; Freitag, F.; Smith, T.; Silberstein, S.; Tepper, S. Cephalalgia, 2001, 21, 267.
72. Fitzal, S. Anaesthesist, 1997, 46, S65.
73. Burstein, R.; Yarnitsky, D.; Goor-Aryeh, I.; Ransil, B.J.; Bajwa, Z.H. Ann. Neurol., 2000, 47, 614.
74. Burstein, R. Pain, 2001, 89, 107.